| Dr James David Byrum, MD | |
|
2900 Moberly Ln, Bentonville, AR 72712-3748 | |
| (479) 273-1550 | |
| (479) 273-3330 |
| Full Name | Dr James David Byrum |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 2900 Moberly Ln, Bentonville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396703252 | NPI | - | NPPES |
| 116414001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | C7065 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Circle Of Life Hospice | Springdale, AR | Hospice |
| Mercy Hospital Northwest Arkansas | Rogers, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Health Northwest Arkansas Communities | 0648177873 | 265 |
News Archive
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for Injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and commercialization rights for the product in the former Eisai territories of the United States, Canada and Japan.
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.
› Verified 8 days ago
| Entity Name | Mercy Health Northwest Arkansas Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265490916 PECOS PAC ID: 0648177873 Enrollment ID: O20031216000788 |
News Archive
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for Injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and commercialization rights for the product in the former Eisai territories of the United States, Canada and Japan.
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James David Byrum, MD 2900 Moberly Ln, Bentonville, AR 72712-3748 Ph: (479) 273-1550 | Dr James David Byrum, MD 2900 Moberly Ln, Bentonville, AR 72712-3748 Ph: (479) 273-1550 |
News Archive
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for Injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and commercialization rights for the product in the former Eisai territories of the United States, Canada and Japan.
BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.
› Verified 8 days ago
Mr. Lance Lee Hamilton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2618 Se J St, Ste 12, Bentonville, AR 72712 Phone: 479-715-6505 Fax: 479-340-0015 | |
Jose Gregorio Loyo-molina, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 Medical Center Pkwy, Suite 240a, Bentonville, AR 72712 Phone: 479-553-2200 Fax: 479-553-2909 | |
Dr. Najindra Maharjan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 811 Se 28th St, Suite 7, Bentonville, AR 72712 Phone: 479-271-9393 Fax: 479-271-0141 | |
Dr. Jamon R Pruitt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 Medical Center Pkwy, Suite 240b, Bentonville, AR 72712 Phone: 479-553-2200 Fax: 479-553-2909 | |
Rupali Abhijit Paradkar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Se 13th Ct, Bentonville, AR 72712 Phone: 479-273-9056 Fax: 479-273-6937 | |
Daniel Young, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 Medical Center Pkwy Ste 240b, Bentonville, AR 72712 Phone: 479-273-9173 | |
Dr. Jason M Bailey, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 Medical Center Pkwy Ste 310, Bentonville, AR 72712 Phone: 479-553-3310 Fax: 479-553-1945 |